PMCTPharmaCountry
    Inicio

Actualizaciones regulatorias

Novedades regulatorias de FDA, EMA, TGA y organismos globales

#Olanzapine ×

UPDATED
Actualizaciones regulatorias
18 sept 2026•1 min de lectura
FDA Approves Teva Olanzapine/Fluoxetine Combination (ANDA077528)
FDA has approved Teva Pharmaceuticals' ANDA077528 for an oral capsule combining olanzapine and fluoxetine, with several dosage strengths, as of Feb 26 2021.
UPDATED
Actualizaciones regulatorias
12 sept 2026•1 min de lectura
FDA Approves Teva Generic Olanzapine (ANDA 077243)
The FDA has approved Teva Pharmaceuticals’ generic olanzapine oral tablets (5‑20 mg) under ANDA 077243, with several labeling supplements filed since 2014.